

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.48023807 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.48023807 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.38405980 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.38405980 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.82717130 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.36862824 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.36862824 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.36862824 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.25290625 |
| 10 | cysteine metabolic process (GO:0006534) | 5.18160109 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.09359602 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.07000031 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.02477779 |
| 14 | glyoxylate metabolic process (GO:0046487) | 4.96646868 |
| 15 | nitrogen cycle metabolic process (GO:0071941) | 4.87523377 |
| 16 | serine family amino acid catabolic process (GO:0009071) | 4.82676502 |
| 17 | regulation of cholesterol esterification (GO:0010872) | 4.80542877 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 4.80057104 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 4.75277225 |
| 20 | regulation of protein activation cascade (GO:2000257) | 4.62153177 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.57605519 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 4.53413374 |
| 23 | urea metabolic process (GO:0019627) | 4.51008827 |
| 24 | urea cycle (GO:0000050) | 4.51008827 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.50085358 |
| 26 | protein carboxylation (GO:0018214) | 4.50085358 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.49947641 |
| 28 | complement activation, alternative pathway (GO:0006957) | 4.49644366 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 4.43372527 |
| 30 | amino-acid betaine metabolic process (GO:0006577) | 4.38554858 |
| 31 | glycine metabolic process (GO:0006544) | 4.38333640 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 4.38216325 |
| 33 | regulation of complement activation (GO:0030449) | 4.36594878 |
| 34 | bile acid metabolic process (GO:0008206) | 4.31271729 |
| 35 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.26240794 |
| 36 | coenzyme catabolic process (GO:0009109) | 4.07397908 |
| 37 | serine family amino acid metabolic process (GO:0009069) | 3.99106557 |
| 38 | lysine metabolic process (GO:0006553) | 3.98933701 |
| 39 | lysine catabolic process (GO:0006554) | 3.98933701 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 3.98301971 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 3.91910779 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 3.91687133 |
| 43 | macromolecular complex remodeling (GO:0034367) | 3.91687133 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 3.91687133 |
| 45 | bile acid and bile salt transport (GO:0015721) | 3.91471411 |
| 46 | amine catabolic process (GO:0009310) | 3.87750368 |
| 47 | cellular biogenic amine catabolic process (GO:0042402) | 3.87750368 |
| 48 | phospholipid efflux (GO:0033700) | 3.87695010 |
| 49 | reverse cholesterol transport (GO:0043691) | 3.80480793 |
| 50 | triglyceride homeostasis (GO:0070328) | 3.80431163 |
| 51 | acylglycerol homeostasis (GO:0055090) | 3.80431163 |
| 52 | tyrosine metabolic process (GO:0006570) | 3.78514657 |
| 53 | fibrinolysis (GO:0042730) | 3.76148628 |
| 54 | homocysteine metabolic process (GO:0050667) | 3.73838315 |
| 55 | cellular glucuronidation (GO:0052695) | 3.72905082 |
| 56 | benzene-containing compound metabolic process (GO:0042537) | 3.70050616 |
| 57 | cellular amino acid catabolic process (GO:0009063) | 3.68810734 |
| 58 | serine family amino acid biosynthetic process (GO:0009070) | 3.65095962 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 3.64160103 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 3.63866451 |
| 61 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.61998594 |
| 62 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.61998594 |
| 63 | response to peptidoglycan (GO:0032494) | 3.61005879 |
| 64 | cofactor catabolic process (GO:0051187) | 3.60282864 |
| 65 | blood coagulation, intrinsic pathway (GO:0007597) | 3.58371138 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 3.58274693 |
| 67 | negative regulation of sterol transport (GO:0032372) | 3.56447796 |
| 68 | negative regulation of cholesterol transport (GO:0032375) | 3.56447796 |
| 69 | low-density lipoprotein particle remodeling (GO:0034374) | 3.52943196 |
| 70 | arginine metabolic process (GO:0006525) | 3.51888193 |
| 71 | intestinal cholesterol absorption (GO:0030299) | 3.47749295 |
| 72 | regulation of cholesterol homeostasis (GO:2000188) | 3.46932178 |
| 73 | plasma lipoprotein particle clearance (GO:0034381) | 3.45290550 |
| 74 | heme transport (GO:0015886) | 3.41832557 |
| 75 | complement activation, classical pathway (GO:0006958) | 3.40016788 |
| 76 | uronic acid metabolic process (GO:0006063) | 3.38698873 |
| 77 | glucuronate metabolic process (GO:0019585) | 3.38698873 |
| 78 | carboxylic acid catabolic process (GO:0046395) | 3.37951103 |
| 79 | organic acid catabolic process (GO:0016054) | 3.37951103 |
| 80 | aldehyde catabolic process (GO:0046185) | 3.36992136 |
| 81 | ethanol oxidation (GO:0006069) | 3.36636177 |
| 82 | urate metabolic process (GO:0046415) | 3.35139571 |
| 83 | carnitine metabolic process (GO:0009437) | 3.34818425 |
| 84 | cellular modified amino acid catabolic process (GO:0042219) | 3.33904158 |
| 85 | protein activation cascade (GO:0072376) | 3.33112576 |
| 86 | cholesterol efflux (GO:0033344) | 3.32810983 |
| 87 | NAD biosynthetic process (GO:0009435) | 3.31728854 |
| 88 | complement activation (GO:0006956) | 3.31538303 |
| 89 | xenobiotic catabolic process (GO:0042178) | 3.30107491 |
| 90 | 2-oxoglutarate metabolic process (GO:0006103) | 3.27001837 |
| 91 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.23349919 |
| 92 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.23349919 |
| 93 | regulation of bile acid biosynthetic process (GO:0070857) | 3.22884012 |
| 94 | acetyl-CoA metabolic process (GO:0006084) | 3.21450790 |
| 95 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.19626933 |
| 96 | negative regulation of cell killing (GO:0031342) | 3.18862578 |
| 97 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.18862578 |
| 98 | fatty acid catabolic process (GO:0009062) | 3.16401223 |
| 99 | monocarboxylic acid catabolic process (GO:0072329) | 3.16341506 |
| 100 | cholesterol homeostasis (GO:0042632) | 3.16163430 |
| 101 | fatty acid oxidation (GO:0019395) | 3.15308270 |
| 102 | glutamate metabolic process (GO:0006536) | 3.13797424 |
| 103 | detection of other organism (GO:0098543) | 3.13709452 |
| 104 | regulation of cholesterol metabolic process (GO:0090181) | 3.13635011 |
| 105 | detection of bacterium (GO:0016045) | 3.12603789 |
| 106 | response to nitrosative stress (GO:0051409) | 3.11445001 |
| 107 | macrophage activation involved in immune response (GO:0002281) | 3.08069558 |
| 108 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.01382097 |
| 109 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.01382097 |
| 110 | modulation by symbiont of host immune response (GO:0052553) | 3.01382097 |
| 111 | positive regulation by symbiont of host defense response (GO:0052509) | 3.01382097 |
| 112 | modulation by symbiont of host defense response (GO:0052031) | 3.01382097 |
| 113 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.01382097 |
| 114 | mannose metabolic process (GO:0006013) | 2.98006073 |
| 115 | negative regulation of interleukin-12 production (GO:0032695) | 2.95704367 |
| 116 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95197606 |
| 117 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.94591130 |
| 118 | low-density lipoprotein particle clearance (GO:0034383) | 2.91416660 |
| 119 | detection of external biotic stimulus (GO:0098581) | 2.88570961 |
| 120 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.85082693 |
| 121 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.82301435 |
| 122 | detection of molecule of bacterial origin (GO:0032490) | 2.80261746 |
| 123 | germinal center formation (GO:0002467) | 2.80042534 |
| 124 | neutrophil activation involved in immune response (GO:0002283) | 2.77952967 |
| 125 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.77894214 |
| 126 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.75165855 |
| 127 | response to muramyl dipeptide (GO:0032495) | 2.74690943 |
| 128 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.73293793 |
| 129 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.73022498 |
| 130 | regulation of leukocyte degranulation (GO:0043300) | 2.66526238 |
| 131 | immunoglobulin mediated immune response (GO:0016064) | 2.66094990 |
| 132 | barbed-end actin filament capping (GO:0051016) | 2.65062253 |
| 133 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.64817452 |
| 134 | negative regulation of granulocyte differentiation (GO:0030853) | 2.61017156 |
| 135 | acute-phase response (GO:0006953) | 2.60239544 |
| 136 | protein localization to endosome (GO:0036010) | 2.59454246 |
| 137 | regulation of mast cell degranulation (GO:0043304) | 2.59250532 |
| 138 | positive regulation of extracellular matrix organization (GO:1903055) | 2.58981382 |
| 139 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.57929785 |
| 140 | detection of biotic stimulus (GO:0009595) | 2.57339659 |
| 141 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.56454095 |
| 142 | regulation of cholesterol storage (GO:0010885) | 2.51456422 |
| 143 | response to thyroid hormone (GO:0097066) | 2.50795158 |
| 144 | activation of MAPKKK activity (GO:0000185) | 2.49848099 |
| 145 | NIK/NF-kappaB signaling (GO:0038061) | 2.47468030 |
| 146 | positive regulation of cholesterol efflux (GO:0010875) | 2.46326211 |
| 147 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.44874126 |
| 148 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.43847862 |
| 149 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.41133928 |
| 150 | regulation of gamma-delta T cell activation (GO:0046643) | 2.38592104 |
| 151 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.36564491 |
| 152 | adhesion of symbiont to host (GO:0044406) | 2.36063167 |
| 153 | regulation of regulated secretory pathway (GO:1903305) | 2.34131848 |
| 154 | glycosphingolipid catabolic process (GO:0046479) | 2.32407245 |
| 155 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.29106331 |
| 156 | adhesion of symbiont to host cell (GO:0044650) | 2.28547304 |
| 157 | virion attachment to host cell (GO:0019062) | 2.28547304 |
| 158 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.28305793 |
| 159 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.27408434 |
| 160 | modulation by symbiont of host cellular process (GO:0044068) | 2.26564268 |
| 161 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.26398300 |
| 162 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.24403140 |
| 163 | positive thymic T cell selection (GO:0045059) | 2.23641232 |
| 164 | pinocytosis (GO:0006907) | 2.23296763 |
| 165 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.23261322 |
| 166 | positive regulation of phagocytosis (GO:0050766) | 2.22965041 |
| 167 | negative regulation of innate immune response (GO:0045824) | 2.22678060 |
| 168 | N-acetylneuraminate metabolic process (GO:0006054) | 2.22307478 |
| 169 | positive regulation of type 2 immune response (GO:0002830) | 2.18823782 |
| 170 | positive regulation of hemostasis (GO:1900048) | 2.18260054 |
| 171 | positive regulation of blood coagulation (GO:0030194) | 2.18260054 |
| 172 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.18192696 |
| 173 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.18192696 |
| 174 | regulation of early endosome to late endosome transport (GO:2000641) | 2.18149220 |
| 175 | regulation of monocyte differentiation (GO:0045655) | 2.17139710 |
| 176 | myeloid dendritic cell differentiation (GO:0043011) | 2.16943426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.74590367 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.73059861 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.88705337 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.41049179 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.90212840 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.81070891 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.71508372 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.49711922 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.68300704 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.77486863 |
| 11 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.62085188 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.49207722 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48968205 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.30311362 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25798299 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16871325 |
| 17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.11700578 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.00861505 |
| 19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.00859808 |
| 20 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.97457030 |
| 21 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.95380719 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94103907 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92121607 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.82785542 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77688120 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 1.76527524 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.75486766 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73765405 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71354219 |
| 30 | P68_20966046_ChIP-Seq_HELA_Human | 1.69958939 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.68902343 |
| 32 | KDM2B_26808549_Chip-Seq_K562_Human | 1.68100643 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.64620455 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64044330 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.61735287 |
| 36 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.57760596 |
| 37 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56622043 |
| 38 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.55672614 |
| 39 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.54278296 |
| 40 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.51226788 |
| 41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.50470814 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50297646 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49642006 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48364746 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48155426 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47648455 |
| 47 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.46550554 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.46114054 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46065689 |
| 50 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46052939 |
| 51 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.44704591 |
| 52 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44019825 |
| 53 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.43439776 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42085296 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41246262 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38391248 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37772321 |
| 58 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.35657651 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.34798628 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34596160 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31835633 |
| 62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31099539 |
| 63 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29664495 |
| 64 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.29489772 |
| 65 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29474325 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28666036 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27398237 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.26748111 |
| 69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24946159 |
| 70 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23270143 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22464821 |
| 72 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20934392 |
| 73 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.20725816 |
| 74 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.20175896 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.19643720 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.18621617 |
| 77 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.17883929 |
| 78 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17550270 |
| 79 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.17514390 |
| 80 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15535038 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15529176 |
| 82 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15222446 |
| 83 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14900717 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13136826 |
| 85 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.12916598 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12428406 |
| 87 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11409460 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10529438 |
| 89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09310845 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09186404 |
| 91 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07625851 |
| 92 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07608910 |
| 93 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05676176 |
| 94 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.05616975 |
| 95 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.04830128 |
| 96 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04731542 |
| 97 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03810893 |
| 98 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03540586 |
| 99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03446799 |
| 100 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.03436228 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02517624 |
| 102 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02492561 |
| 103 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.02485962 |
| 104 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.02165794 |
| 105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01984672 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01419343 |
| 107 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.00520571 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97799896 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96765830 |
| 110 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.95874424 |
| 111 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94929200 |
| 112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94213311 |
| 113 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92722560 |
| 114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.92317358 |
| 115 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90717694 |
| 116 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88783384 |
| 117 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88572155 |
| 118 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87922769 |
| 119 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86457789 |
| 120 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.85647489 |
| 121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85352327 |
| 122 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84193771 |
| 123 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84146307 |
| 124 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83770929 |
| 125 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.83430896 |
| 126 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83121095 |
| 127 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82124568 |
| 128 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79880478 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79111001 |
| 130 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78445511 |
| 131 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77802541 |
| 132 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.76271752 |
| 133 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.76027445 |
| 134 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75942394 |
| 135 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.75851500 |
| 136 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.75561821 |
| 137 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.74965756 |
| 138 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.74558988 |
| 139 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.73411374 |
| 140 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72699521 |
| 141 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72692092 |
| 142 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71460741 |
| 143 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.71209304 |
| 144 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.70883997 |
| 145 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.70820443 |
| 146 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70574322 |
| 147 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69813133 |
| 148 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69333444 |
| 149 | AR_20517297_ChIP-Seq_VCAP_Human | 0.68598783 |
| 150 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.68417289 |
| 151 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.67959185 |
| 152 | GATA1_19941826_ChIP-Seq_K562_Human | 0.67306869 |
| 153 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.66930443 |
| 154 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.65097426 |
| 155 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.65095267 |
| 156 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.65053284 |
| 157 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.65000149 |
| 158 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.62664191 |
| 159 | SA1_27219007_Chip-Seq_Bcells_Human | 0.62063640 |
| 160 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62015078 |
| 161 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61553291 |
| 162 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.61330773 |
| 163 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.61056733 |
| 164 | ATF3_27146783_Chip-Seq_COLON_Human | 0.60909773 |
| 165 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.60853883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.75153805 |
| 2 | MP0005360_urolithiasis | 5.95472150 |
| 3 | MP0005365_abnormal_bile_salt | 5.61089234 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.58977407 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.43299592 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.10276180 |
| 7 | MP0005083_abnormal_biliary_tract | 3.85656588 |
| 8 | MP0003303_peritoneal_inflammation | 3.85469830 |
| 9 | MP0009840_abnormal_foam_cell | 3.81455317 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.08938923 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.81391267 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.74199108 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.71864860 |
| 14 | MP0005332_abnormal_amino_acid | 2.62522944 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.60615033 |
| 16 | MP0003195_calcinosis | 2.54747101 |
| 17 | MP0003252_abnormal_bile_duct | 2.42388798 |
| 18 | MP0004510_myositis | 2.09933219 |
| 19 | MP0009278_abnormal_bone_marrow | 2.06408354 |
| 20 | MP0000685_abnormal_immune_system | 1.95560131 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.93364527 |
| 22 | MP0000609_abnormal_liver_physiology | 1.91585575 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.90321077 |
| 24 | MP0003868_abnormal_feces_composition | 1.89715430 |
| 25 | MP0006082_CNS_inflammation | 1.88740923 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.86204848 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.85865906 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.84278919 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.81369841 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.81100228 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.80696901 |
| 32 | MP0001764_abnormal_homeostasis | 1.76794715 |
| 33 | MP0001790_abnormal_immune_system | 1.76346623 |
| 34 | MP0005387_immune_system_phenotype | 1.76346623 |
| 35 | MP0004147_increased_porphyrin_level | 1.71723468 |
| 36 | MP0005451_abnormal_body_composition | 1.64383168 |
| 37 | MP0003186_abnormal_redox_activity | 1.62826860 |
| 38 | MP0003690_abnormal_glial_cell | 1.58493541 |
| 39 | MP0003879_abnormal_hair_cell | 1.55310709 |
| 40 | MP0009697_abnormal_copulation | 1.52854750 |
| 41 | MP0005167_abnormal_blood-brain_barrier | 1.50838077 |
| 42 | MP0008260_abnormal_autophagy | 1.46703290 |
| 43 | MP0002723_abnormal_immune_serum | 1.45402458 |
| 44 | MP0001800_abnormal_humoral_immune | 1.41274804 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.40126698 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.38934339 |
| 47 | MP0000343_altered_response_to | 1.38515659 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 1.37801311 |
| 49 | MP0003724_increased_susceptibility_to | 1.37598874 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.37089436 |
| 51 | MP0005166_decreased_susceptibility_to | 1.35191197 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32990387 |
| 53 | MP0005671_abnormal_response_to | 1.32793565 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.32642291 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.30913826 |
| 56 | MP0001819_abnormal_immune_cell | 1.29638066 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.29599249 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.28633890 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.25375616 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 1.23939647 |
| 61 | MP0003828_pulmonary_edema | 1.21273191 |
| 62 | MP0009764_decreased_sensitivity_to | 1.20289915 |
| 63 | MP0000858_altered_metastatic_potential | 1.17207840 |
| 64 | MP0010368_abnormal_lymphatic_system | 1.16214916 |
| 65 | MP0002405_respiratory_system_inflammati | 1.15136817 |
| 66 | MP0001849_ear_inflammation | 1.14741319 |
| 67 | MP0008874_decreased_physiological_sensi | 1.14150550 |
| 68 | MP0005666_abnormal_adipose_tissue | 1.14138026 |
| 69 | MP0008469_abnormal_protein_level | 1.09957875 |
| 70 | MP0005084_abnormal_gallbladder_morpholo | 1.09360394 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.09316813 |
| 72 | MP0000598_abnormal_liver_morphology | 1.08538792 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 1.08443296 |
| 74 | MP0002132_abnormal_respiratory_system | 1.06344362 |
| 75 | MP0003011_delayed_dark_adaptation | 1.05685037 |
| 76 | MP0000604_amyloidosis | 1.04846693 |
| 77 | MP0002254_reproductive_system_inflammat | 1.03876223 |
| 78 | MP0005310_abnormal_salivary_gland | 1.00658272 |
| 79 | MP0000920_abnormal_myelination | 1.00384938 |
| 80 | MP0002971_abnormal_brown_adipose | 1.00136543 |
| 81 | MP0009763_increased_sensitivity_to | 0.99799490 |
| 82 | MP0005464_abnormal_platelet_physiology | 0.97846359 |
| 83 | MP0002796_impaired_skin_barrier | 0.94455952 |
| 84 | MP0003436_decreased_susceptibility_to | 0.93820126 |
| 85 | MP0000716_abnormal_immune_system | 0.93327737 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.93054271 |
| 87 | MP0004858_abnormal_nervous_system | 0.91845937 |
| 88 | MP0003279_aneurysm | 0.90914583 |
| 89 | MP0009379_abnormal_foot_pigmentation | 0.89695251 |
| 90 | MP0004381_abnormal_hair_follicle | 0.88466839 |
| 91 | MP0009642_abnormal_blood_homeostasis | 0.87815603 |
| 92 | MP0005375_adipose_tissue_phenotype | 0.86713688 |
| 93 | MP0008004_abnormal_stomach_pH | 0.86445987 |
| 94 | MP0004859_abnormal_synaptic_plasticity | 0.85721637 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.85323441 |
| 96 | MP0000249_abnormal_blood_vessel | 0.84699668 |
| 97 | MP0003091_abnormal_cell_migration | 0.84213594 |
| 98 | MP0005647_abnormal_sex_gland | 0.84173580 |
| 99 | MP0002837_dystrophic_cardiac_calcinosis | 0.84041509 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 0.83553280 |
| 101 | MP0001756_abnormal_urination | 0.83074525 |
| 102 | MP0002933_joint_inflammation | 0.82621216 |
| 103 | MP0003763_abnormal_thymus_physiology | 0.82577531 |
| 104 | MP0002398_abnormal_bone_marrow | 0.82005409 |
| 105 | MP0001851_eye_inflammation | 0.81071361 |
| 106 | MP0005390_skeleton_phenotype | 0.79135670 |
| 107 | MP0003718_maternal_effect | 0.79120102 |
| 108 | MP0005076_abnormal_cell_differentiation | 0.77880307 |
| 109 | MP0003705_abnormal_hypodermis_morpholog | 0.77421144 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.77046578 |
| 111 | MP0006035_abnormal_mitochondrial_morpho | 0.76268556 |
| 112 | MP0005023_abnormal_wound_healing | 0.74486456 |
| 113 | MP0001663_abnormal_digestive_system | 0.73666259 |
| 114 | MP0002429_abnormal_blood_cell | 0.72959278 |
| 115 | MP0004130_abnormal_muscle_cell | 0.70261965 |
| 116 | MP0003329_amyloid_beta_deposits | 0.69519116 |
| 117 | MP0000689_abnormal_spleen_morphology | 0.67957817 |
| 118 | MP0005058_abnormal_lysosome_morphology | 0.67948962 |
| 119 | MP0002722_abnormal_immune_system | 0.67668396 |
| 120 | MP0001542_abnormal_bone_strength | 0.66566269 |
| 121 | MP0005535_abnormal_body_temperature | 0.65874808 |
| 122 | MP0002078_abnormal_glucose_homeostasis | 0.64643592 |
| 123 | MP0006276_abnormal_autonomic_nervous | 0.63355705 |
| 124 | MP0001986_abnormal_taste_sensitivity | 0.62723762 |
| 125 | MP0002735_abnormal_chemical_nociception | 0.62614401 |
| 126 | MP0005397_hematopoietic_system_phenotyp | 0.61820007 |
| 127 | MP0001545_abnormal_hematopoietic_system | 0.61820007 |
| 128 | MP0005408_hypopigmentation | 0.60196529 |
| 129 | MP0005266_abnormal_metabolism | 0.59654625 |
| 130 | MP0005334_abnormal_fat_pad | 0.59621888 |
| 131 | MP0001845_abnormal_inflammatory_respons | 0.59558472 |
| 132 | MP0003646_muscle_fatigue | 0.57320711 |
| 133 | MP0001853_heart_inflammation | 0.56911480 |
| 134 | MP0002419_abnormal_innate_immunity | 0.56387813 |
| 135 | MP0008873_increased_physiological_sensi | 0.56278877 |
| 136 | MP0004883_abnormal_blood_vessel | 0.55419552 |
| 137 | MP0003638_abnormal_response/metabolism_ | 0.54538911 |
| 138 | MP0002060_abnormal_skin_morphology | 0.54490932 |
| 139 | MP0000465_gastrointestinal_hemorrhage | 0.53862079 |
| 140 | MP0004947_skin_inflammation | 0.53304152 |
| 141 | MP0005448_abnormal_energy_balance | 0.51645188 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.51463757 |
| 143 | MP0009931_abnormal_skin_appearance | 0.51216098 |
| 144 | MP0000579_abnormal_nail_morphology | 0.51179356 |
| 145 | MP0001661_extended_life_span | 0.51018123 |
| 146 | MP0005670_abnormal_white_adipose | 0.50622390 |
| 147 | MP0005165_increased_susceptibility_to | 0.50574242 |
| 148 | MP0000230_abnormal_systemic_arterial | 0.49625562 |
| 149 | MP0002136_abnormal_kidney_physiology | 0.48890983 |
| 150 | MP0005164_abnormal_response_to | 0.48088825 |
| 151 | MP0001243_abnormal_dermal_layer | 0.46416023 |
| 152 | MP0005025_abnormal_response_to | 0.45668224 |
| 153 | MP0002332_abnormal_exercise_endurance | 0.45583522 |
| 154 | MP0005075_abnormal_melanosome_morpholog | 0.45353600 |
| 155 | MP0003075_altered_response_to | 0.44721883 |
| 156 | MP0001216_abnormal_epidermal_layer | 0.44401266 |
| 157 | MP0009785_altered_susceptibility_to | 0.43771576 |
| 158 | MP0005595_abnormal_vascular_smooth | 0.42766524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.37379387 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.52331723 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.50230343 |
| 4 | Xanthomatosis (HP:0000991) | 5.20139056 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.12216131 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.02712127 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.66516463 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.56667509 |
| 9 | Complement deficiency (HP:0004431) | 4.27558387 |
| 10 | Hyperglycinemia (HP:0002154) | 4.24787935 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.12374174 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.12374174 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 4.12374174 |
| 14 | Joint hemorrhage (HP:0005261) | 3.77250727 |
| 15 | Hyperammonemia (HP:0001987) | 3.71806918 |
| 16 | Hyperglycinuria (HP:0003108) | 3.61614376 |
| 17 | Fat malabsorption (HP:0002630) | 3.58081985 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.57011881 |
| 19 | Eczematoid dermatitis (HP:0000976) | 3.56567061 |
| 20 | Hypolipoproteinemia (HP:0010981) | 3.56280636 |
| 21 | Ketosis (HP:0001946) | 3.50510880 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 3.50134356 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.43082572 |
| 24 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.42727684 |
| 25 | Conjugated hyperbilirubinemia (HP:0002908) | 3.40703506 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.39606761 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.39606761 |
| 28 | Abnormality of macrophages (HP:0004311) | 3.34001542 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.32698869 |
| 30 | Abnormality of complement system (HP:0005339) | 3.29781935 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.28578506 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.27730902 |
| 33 | Purpura (HP:0000979) | 3.25158972 |
| 34 | Epidermoid cyst (HP:0200040) | 3.21845555 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 3.20925194 |
| 36 | Abnormality of methionine metabolism (HP:0010901) | 3.17665497 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.17211452 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.16673445 |
| 39 | Gout (HP:0001997) | 3.15063994 |
| 40 | Hypoglycemic coma (HP:0001325) | 3.12916242 |
| 41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.06145928 |
| 42 | Neurofibrillary tangles (HP:0002185) | 3.04595368 |
| 43 | Steatorrhea (HP:0002570) | 3.04126641 |
| 44 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.00471047 |
| 45 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.98528319 |
| 46 | Myositis (HP:0100614) | 2.97230118 |
| 47 | Recurrent abscess formation (HP:0002722) | 2.93948402 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.92439952 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.91405781 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.86168589 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.86168589 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.86168589 |
| 53 | Orchitis (HP:0100796) | 2.84955835 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.79755277 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.79755277 |
| 56 | Lethargy (HP:0001254) | 2.77735353 |
| 57 | Loss of speech (HP:0002371) | 2.72637659 |
| 58 | Abnormality of nucleobase metabolism (HP:0010932) | 2.71190510 |
| 59 | Recurrent bacterial skin infections (HP:0005406) | 2.69178141 |
| 60 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.69045219 |
| 61 | Mucopolysacchariduria (HP:0008155) | 2.69045219 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.68487778 |
| 63 | Hypercholesterolemia (HP:0003124) | 2.67565369 |
| 64 | Cerebral edema (HP:0002181) | 2.65621734 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.63855510 |
| 66 | Cerebral inclusion bodies (HP:0100314) | 2.62708147 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.60915528 |
| 68 | Abnormality of purine metabolism (HP:0004352) | 2.57521606 |
| 69 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.57376911 |
| 70 | Vacuolated lymphocytes (HP:0001922) | 2.56820236 |
| 71 | Hemorrhage of the eye (HP:0011885) | 2.55311466 |
| 72 | Metabolic acidosis (HP:0001942) | 2.54792220 |
| 73 | Axonal loss (HP:0003447) | 2.52740394 |
| 74 | Increased IgE level (HP:0003212) | 2.50179937 |
| 75 | Myocardial infarction (HP:0001658) | 2.44971083 |
| 76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.44377758 |
| 77 | Retrobulbar optic neuritis (HP:0100654) | 2.42232702 |
| 78 | Optic neuritis (HP:0100653) | 2.42232702 |
| 79 | Obstructive lung disease (HP:0006536) | 2.41072466 |
| 80 | Chronic obstructive pulmonary disease (HP:0006510) | 2.41072466 |
| 81 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.39355298 |
| 82 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.39355298 |
| 83 | Asymmetric septal hypertrophy (HP:0001670) | 2.38656610 |
| 84 | Increased muscle lipid content (HP:0009058) | 2.37818848 |
| 85 | Spontaneous abortion (HP:0005268) | 2.35291366 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.34785911 |
| 87 | Increased intramyocellular lipid droplets (HP:0012240) | 2.32359784 |
| 88 | Cellulitis (HP:0100658) | 2.31740663 |
| 89 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.31238908 |
| 90 | Poikilocytosis (HP:0004447) | 2.31083895 |
| 91 | Delayed CNS myelination (HP:0002188) | 2.31055220 |
| 92 | Abnormality of the nasal mucosa (HP:0000433) | 2.30756494 |
| 93 | Supranuclear gaze palsy (HP:0000605) | 2.29825235 |
| 94 | Glomerulonephritis (HP:0000099) | 2.29560154 |
| 95 | Ketoacidosis (HP:0001993) | 2.28347745 |
| 96 | Gingivitis (HP:0000230) | 2.28267805 |
| 97 | Hepatic necrosis (HP:0002605) | 2.27324461 |
| 98 | Abnormality of iron homeostasis (HP:0011031) | 2.26587501 |
| 99 | Acanthocytosis (HP:0001927) | 2.25883758 |
| 100 | Brushfield spots (HP:0001088) | 2.25067258 |
| 101 | Mutism (HP:0002300) | 2.24882068 |
| 102 | Amyloidosis (HP:0011034) | 2.24670825 |
| 103 | Polygenic inheritance (HP:0010982) | 2.23694197 |
| 104 | Abnormal gallbladder morphology (HP:0012437) | 2.23386073 |
| 105 | Hypertriglyceridemia (HP:0002155) | 2.23005205 |
| 106 | Cholelithiasis (HP:0001081) | 2.22062591 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.21936524 |
| 108 | Neuronal loss in central nervous system (HP:0002529) | 2.21515390 |
| 109 | Pancreatitis (HP:0001733) | 2.17953976 |
| 110 | Nausea (HP:0002018) | 2.17113735 |
| 111 | Increased serum ferritin (HP:0003281) | 2.16532639 |
| 112 | Stomatitis (HP:0010280) | 2.16012522 |
| 113 | Prolonged bleeding time (HP:0003010) | 2.15543327 |
| 114 | Nephritis (HP:0000123) | 2.14737160 |
| 115 | Gastrointestinal infarctions (HP:0005244) | 2.14306907 |
| 116 | Abnormality of the Achilles tendon (HP:0005109) | 2.14217895 |
| 117 | Hepatocellular carcinoma (HP:0001402) | 2.13980407 |
| 118 | Irritability (HP:0000737) | 2.12540594 |
| 119 | Polycythemia (HP:0001901) | 2.12437169 |
| 120 | Neonatal onset (HP:0003623) | 2.11524673 |
| 121 | Meningitis (HP:0001287) | 2.09286206 |
| 122 | Vomiting (HP:0002013) | 2.09127470 |
| 123 | Spontaneous hematomas (HP:0007420) | 2.08858920 |
| 124 | Achilles tendon contracture (HP:0001771) | 2.07331999 |
| 125 | Thoracic kyphosis (HP:0002942) | 2.06914537 |
| 126 | Alopecia of scalp (HP:0002293) | 2.06690129 |
| 127 | Palpitations (HP:0001962) | 2.05225749 |
| 128 | Menorrhagia (HP:0000132) | 2.03577272 |
| 129 | Nuclear cataract (HP:0100018) | 2.02372720 |
| 130 | Skin nodule (HP:0200036) | 2.00185723 |
| 131 | Abnormality of urine glucose concentration (HP:0011016) | 1.99181400 |
| 132 | Glycosuria (HP:0003076) | 1.99181400 |
| 133 | Reduced antithrombin III activity (HP:0001976) | 1.98404539 |
| 134 | Pulmonary embolism (HP:0002204) | 1.98046332 |
| 135 | Opisthotonus (HP:0002179) | 1.97890133 |
| 136 | Thrombophlebitis (HP:0004418) | 1.97694305 |
| 137 | Distal lower limb muscle weakness (HP:0009053) | 1.97399380 |
| 138 | Obstructive sleep apnea (HP:0002870) | 1.96855389 |
| 139 | Visual hallucinations (HP:0002367) | 1.96246361 |
| 140 | Nasal polyposis (HP:0100582) | 1.95974810 |
| 141 | Gingival bleeding (HP:0000225) | 1.95331601 |
| 142 | Pathologic fracture (HP:0002756) | 1.95197428 |
| 143 | Petechiae (HP:0000967) | 1.95167593 |
| 144 | Abnormal gallbladder physiology (HP:0012438) | 1.94497043 |
| 145 | Cholecystitis (HP:0001082) | 1.94497043 |
| 146 | Lactic acidosis (HP:0003128) | 1.94179176 |
| 147 | Vertebral compression fractures (HP:0002953) | 1.94128987 |
| 148 | Rhabdomyolysis (HP:0003201) | 1.92322117 |
| 149 | Late onset (HP:0003584) | 1.88047464 |
| 150 | Colitis (HP:0002583) | 1.86404751 |
| 151 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.85477658 |
| 152 | Vasculitis (HP:0002633) | 1.84991754 |
| 153 | Malnutrition (HP:0004395) | 1.84247451 |
| 154 | Hepatocellular necrosis (HP:0001404) | 1.84126805 |
| 155 | Epistaxis (HP:0000421) | 1.83040989 |
| 156 | Gastrointestinal stroma tumor (HP:0100723) | 1.83005790 |
| 157 | Recurrent skin infections (HP:0001581) | 1.82493033 |
| 158 | Pulmonary infiltrates (HP:0002113) | 1.82097784 |
| 159 | Increased purine levels (HP:0004368) | 1.80779891 |
| 160 | Hyperuricemia (HP:0002149) | 1.80779891 |
| 161 | Emphysema (HP:0002097) | 1.80316198 |
| 162 | Dementia (HP:0000726) | 1.79354927 |
| 163 | Abnormality of the thoracic spine (HP:0100711) | 1.78861301 |
| 164 | Vascular calcification (HP:0004934) | 1.78140404 |
| 165 | Hypochromic anemia (HP:0001931) | 1.77104724 |
| 166 | Hyperglycemia (HP:0003074) | 1.76269682 |
| 167 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.75532917 |
| 168 | Thin bony cortex (HP:0002753) | 1.74809630 |
| 169 | Keratoconjunctivitis sicca (HP:0001097) | 1.74484180 |
| 170 | Cerebral palsy (HP:0100021) | 1.73779479 |
| 171 | Abnormality of the gallbladder (HP:0005264) | 1.73241311 |
| 172 | Cerebral aneurysm (HP:0004944) | 1.72273022 |
| 173 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.72267983 |
| 174 | Acute encephalopathy (HP:0006846) | 1.71102787 |
| 175 | Progressive neurologic deterioration (HP:0002344) | 1.71031335 |
| 176 | Abnormality of the periventricular white matter (HP:0002518) | 1.69811987 |
| 177 | Urticaria (HP:0001025) | 1.69511293 |
| 178 | Hepatosplenomegaly (HP:0001433) | 1.69483594 |
| 179 | Acne (HP:0001061) | 1.69358008 |
| 180 | Diminished motivation (HP:0000745) | 1.67448688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.03346136 |
| 2 | ERN1 | 3.82163223 |
| 3 | NME2 | 3.78301060 |
| 4 | PRPF4B | 3.77550492 |
| 5 | MAP2K3 | 2.87441838 |
| 6 | FGFR4 | 2.69993423 |
| 7 | MAP3K3 | 2.39679718 |
| 8 | MAPKAPK3 | 2.33253980 |
| 9 | RIPK1 | 2.19294275 |
| 10 | STK16 | 2.15876784 |
| 11 | FLT3 | 1.91908865 |
| 12 | PIM2 | 1.91247257 |
| 13 | KDR | 1.89722305 |
| 14 | ARAF | 1.83172731 |
| 15 | TAOK3 | 1.71061242 |
| 16 | IRAK3 | 1.68317334 |
| 17 | TYK2 | 1.65175579 |
| 18 | TAOK1 | 1.62063843 |
| 19 | MAP2K2 | 1.59336243 |
| 20 | PIK3CG | 1.56388530 |
| 21 | MAP2K4 | 1.54216467 |
| 22 | MAP2K6 | 1.53670280 |
| 23 | INSRR | 1.49494368 |
| 24 | BRAF | 1.47333650 |
| 25 | ICK | 1.44182163 |
| 26 | PINK1 | 1.43352515 |
| 27 | SMG1 | 1.39762562 |
| 28 | TIE1 | 1.39736892 |
| 29 | MAP3K12 | 1.37872501 |
| 30 | IRAK4 | 1.34971236 |
| 31 | ABL2 | 1.31752839 |
| 32 | FES | 1.29320099 |
| 33 | TNK2 | 1.27671722 |
| 34 | ZAP70 | 1.26447764 |
| 35 | ERBB4 | 1.25773214 |
| 36 | MATK | 1.25743450 |
| 37 | BUB1 | 1.24169820 |
| 38 | KIT | 1.24096044 |
| 39 | WEE1 | 1.23663384 |
| 40 | CSK | 1.22486192 |
| 41 | MAP3K11 | 1.22230399 |
| 42 | BLK | 1.21213833 |
| 43 | MARK2 | 1.20887190 |
| 44 | MAPK11 | 1.20005628 |
| 45 | DDR2 | 1.19820523 |
| 46 | PDPK1 | 1.18607951 |
| 47 | MST1R | 1.16868699 |
| 48 | MYLK | 1.15744341 |
| 49 | NME1 | 1.15604030 |
| 50 | STK24 | 1.14728030 |
| 51 | SIK1 | 1.13084526 |
| 52 | DAPK2 | 1.10970818 |
| 53 | CAMKK1 | 1.09253424 |
| 54 | TGFBR2 | 1.07750984 |
| 55 | SIK2 | 1.07123861 |
| 56 | TESK1 | 1.05710986 |
| 57 | EPHA3 | 1.05177824 |
| 58 | EEF2K | 1.03588517 |
| 59 | EPHA2 | 1.01689995 |
| 60 | TBK1 | 1.00894724 |
| 61 | PRKD2 | 1.00186218 |
| 62 | CDC42BPA | 0.99967482 |
| 63 | NEK9 | 0.98482301 |
| 64 | JAK3 | 0.97315813 |
| 65 | GRK6 | 0.96076745 |
| 66 | PDK1 | 0.95458381 |
| 67 | MOS | 0.95083381 |
| 68 | PRKD3 | 0.94983241 |
| 69 | MAP2K1 | 0.94864029 |
| 70 | MAP4K1 | 0.94354568 |
| 71 | RPS6KA2 | 0.92612044 |
| 72 | ZAK | 0.91084757 |
| 73 | RIPK4 | 0.90636389 |
| 74 | MAPK4 | 0.89758033 |
| 75 | TESK2 | 0.87494666 |
| 76 | PKN2 | 0.87223963 |
| 77 | PAK6 | 0.84994621 |
| 78 | TTN | 0.82928731 |
| 79 | RPS6KC1 | 0.82530470 |
| 80 | RPS6KL1 | 0.82530470 |
| 81 | GRK5 | 0.82325797 |
| 82 | PDK3 | 0.79678142 |
| 83 | PDK4 | 0.79678142 |
| 84 | DYRK3 | 0.79514922 |
| 85 | IKBKE | 0.78909008 |
| 86 | EIF2AK1 | 0.78219440 |
| 87 | FGR | 0.75887421 |
| 88 | MAP3K1 | 0.73229267 |
| 89 | AKT3 | 0.73059150 |
| 90 | HCK | 0.72454801 |
| 91 | BMX | 0.72352357 |
| 92 | MAP3K5 | 0.71578768 |
| 93 | MAP3K6 | 0.71469235 |
| 94 | PDK2 | 0.69921582 |
| 95 | JAK1 | 0.68802982 |
| 96 | CAMK1D | 0.68517594 |
| 97 | EIF2AK3 | 0.68037812 |
| 98 | MAP3K2 | 0.67347052 |
| 99 | RPS6KA6 | 0.66199685 |
| 100 | MAPK12 | 0.65701473 |
| 101 | ADRBK2 | 0.65091003 |
| 102 | HIPK2 | 0.64002345 |
| 103 | GRK7 | 0.63152286 |
| 104 | RPS6KA4 | 0.62342738 |
| 105 | JAK2 | 0.62103715 |
| 106 | BRSK2 | 0.61898607 |
| 107 | PTK6 | 0.58737960 |
| 108 | MAP3K7 | 0.57960388 |
| 109 | TYRO3 | 0.56947538 |
| 110 | MAP3K13 | 0.56721203 |
| 111 | TAOK2 | 0.55382737 |
| 112 | TGFBR1 | 0.54971554 |
| 113 | LYN | 0.53513087 |
| 114 | MAPK15 | 0.53496107 |
| 115 | MAPK7 | 0.53257890 |
| 116 | BMPR1B | 0.53242827 |
| 117 | DYRK1B | 0.52921270 |
| 118 | TEC | 0.52810167 |
| 119 | STK38 | 0.52727721 |
| 120 | OBSCN | 0.52489705 |
| 121 | IRAK2 | 0.48805330 |
| 122 | EPHB1 | 0.48176402 |
| 123 | AURKA | 0.46752484 |
| 124 | MAP3K9 | 0.46568714 |
| 125 | MAP3K14 | 0.45658716 |
| 126 | MARK3 | 0.45522363 |
| 127 | TXK | 0.44989865 |
| 128 | PRKG2 | 0.44781112 |
| 129 | SGK3 | 0.44152376 |
| 130 | SYK | 0.44011426 |
| 131 | LCK | 0.42260091 |
| 132 | RPS6KB2 | 0.42257465 |
| 133 | CDK8 | 0.41980139 |
| 134 | RET | 0.41732380 |
| 135 | CAMKK2 | 0.40892806 |
| 136 | IKBKB | 0.40536030 |
| 137 | TRIB3 | 0.40412789 |
| 138 | NTRK1 | 0.39558135 |
| 139 | KSR2 | 0.39237620 |
| 140 | PIK3CA | 0.39204641 |
| 141 | CAMK2G | 0.38899372 |
| 142 | DAPK3 | 0.37867518 |
| 143 | ERBB2 | 0.37861315 |
| 144 | PRKACG | 0.37466578 |
| 145 | IRAK1 | 0.36984540 |
| 146 | LMTK2 | 0.36975209 |
| 147 | PRKCH | 0.36566407 |
| 148 | PRKCD | 0.34140434 |
| 149 | CSF1R | 0.33476682 |
| 150 | RAF1 | 0.33032905 |
| 151 | PRKCZ | 0.33028947 |
| 152 | BTK | 0.32774884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.26383046 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.03009269 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.00443614 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.87801952 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65480690 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.61725147 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.60329682 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.41758889 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.38555658 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37481713 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.37005708 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.26889563 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.24400521 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21278612 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.16876084 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.13347955 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13233914 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10805157 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.07915639 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.03212341 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.02438707 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.97506561 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.91153265 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.90315342 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83776624 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.82974532 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80009429 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77860806 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77608368 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75667023 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72754630 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67132584 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.65595673 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65132489 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.58296788 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56926879 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.53810776 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.50746316 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.49493883 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.49438268 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.49121701 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47874258 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.47859480 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.42753526 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41038338 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.40897762 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40808159 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.37442376 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31947845 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31764812 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30741960 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.28424011 |
| 53 | Allograft rejection_Homo sapiens_hsa05330 | 1.25127755 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23186075 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23153162 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21229783 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19532932 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17484442 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 1.15716319 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15101270 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.12444282 |
| 62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.12220103 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11808477 |
| 64 | Bile secretion_Homo sapiens_hsa04976 | 1.11106975 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09253992 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07291003 |
| 67 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06172006 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.04729182 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03660072 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02996422 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02666823 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02427170 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00117447 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98649650 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97337333 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96628382 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.95072450 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94897208 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94010651 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.92890691 |
| 81 | Asthma_Homo sapiens_hsa05310 | 0.91385587 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87584073 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86811923 |
| 84 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86232515 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85038378 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.83397732 |
| 87 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.82951331 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.82027226 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.82010342 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80033342 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77662905 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.77585408 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77468552 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.75911610 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75643691 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75537048 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75413601 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73316986 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72499785 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72128407 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69329912 |
| 102 | Bladder cancer_Homo sapiens_hsa05219 | 0.68939268 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68798475 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68476887 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68377837 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68335140 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67934885 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67132057 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64208899 |
| 110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63862270 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62709955 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.62261828 |
| 113 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61318191 |
| 114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61174392 |
| 115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59649596 |
| 116 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.59518408 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59126753 |
| 118 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58889618 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58590771 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57987269 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57375268 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56860676 |
| 123 | Platelet activation_Homo sapiens_hsa04611 | 0.56728110 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56262258 |
| 125 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55458906 |
| 126 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53203728 |
| 127 | Legionellosis_Homo sapiens_hsa05134 | 0.53042166 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52244602 |
| 129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51491181 |
| 130 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.51363420 |
| 131 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51313240 |
| 132 | Apoptosis_Homo sapiens_hsa04210 | 0.50142447 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49999124 |
| 134 | Proteasome_Homo sapiens_hsa03050 | 0.49877120 |
| 135 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45743780 |
| 136 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45527018 |
| 137 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45432159 |
| 138 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44431680 |
| 139 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43307057 |
| 140 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40601037 |
| 141 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38619596 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.37086103 |
| 143 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.35932771 |
| 144 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.34767183 |
| 145 | Parkinsons disease_Homo sapiens_hsa05012 | 0.34423656 |
| 146 | RNA polymerase_Homo sapiens_hsa03020 | 0.21884730 |
| 147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21341541 |
| 148 | Lysine degradation_Homo sapiens_hsa00310 | 0.20952019 |
| 149 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18937679 |
| 150 | Ribosome_Homo sapiens_hsa03010 | 0.18169733 |
| 151 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14842927 |
| 152 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.12563338 |
| 153 | Lysosome_Homo sapiens_hsa04142 | 0.11712623 |
| 154 | Alzheimers disease_Homo sapiens_hsa05010 | 0.09753256 |
| 155 | Insulin resistance_Homo sapiens_hsa04931 | 0.09698809 |
| 156 | Protein export_Homo sapiens_hsa03060 | 0.09226887 |
| 157 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.04066876 |
| 158 | Huntingtons disease_Homo sapiens_hsa05016 | 0.04013125 |
| 159 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.00480352 |
| 160 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0913721 |
| 161 | Pertussis_Homo sapiens_hsa05133 | -0.0864510 |
| 162 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0596882 |
| 163 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0573567 |
| 164 | Purine metabolism_Homo sapiens_hsa00230 | -0.0490449 |
| 165 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.0373952 |
| 166 | Thyroid cancer_Homo sapiens_hsa05216 | -0.0110536 |

